-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Inovio Pharmaceuticals, Raises Price Target to $6

Benzinga·11/14/2025 16:06:24
Listen to the news
Piper Sandler analyst Edward Tenthoff reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight and raises the price target from $5 to $6.